Alphyn Biologics logo

Alphyn Biologics Funding & Investors

Annapolis, MD

Alphyn Biologics is a life science company that develops proprietary drug therapy for treating skin diseases. Alphyn's initial target indication are skin infections caused by deadly drug-resistant MRSA bacteria based on their proprietary Multi-Target Therapeutic (MTT) plant-derived technology platform.

alphynbiologics.com

Total Amount Raised: $11,828,198

Alphyn Biologics Funding Rounds

  • Series Unknown

    $5,172,484

  • Series Unknown

    $1,185,717

  • Series A

    $3,300,000

    Series A Investors

    Queen City Angels
    Angel Physicians Fund
    Serial Stage Venture Partners

  • Series Unknown

    $2,169,997

Funding info provided by Diffbot.